Clinical trial
Omacor and Placebo in Carotid Plaque Stability
NCT00294216 · Pronova BioPharma, Industry · Completed
Key facts
| NCT number | NCT00294216 |
|---|---|
| Title | Omacor and Placebo in Carotid Plaque Stability |
| Official title | A Double Blind Comparison of Omacor and Placebo in Patients Awaiting Endarterectomy to Investigate the Effect on Carotid Plaque Stability |
| Lead sponsor | Pronova BioPharma, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cardiovascular Disease |
| Intervention type | Drug |
| Interventions | Omega-3-acid ethyl ester 90 (n-3 PUFA) |
| Enrollment | 121 |
| Start date | Aug 1, 2003 |
| Completion | Jul 1, 2005 |
| First posted | Feb 20, 2006 |
| Last update posted | Feb 20, 2006 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: